JPWO2019172358A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2019172358A5 JPWO2019172358A5 JP2020505099A JP2020505099A JPWO2019172358A5 JP WO2019172358 A5 JPWO2019172358 A5 JP WO2019172358A5 JP 2020505099 A JP2020505099 A JP 2020505099A JP 2020505099 A JP2020505099 A JP 2020505099A JP WO2019172358 A5 JPWO2019172358 A5 JP WO2019172358A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- seq
- acid sequence
- terminal
- peptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2018041560 | 2018-03-08 | ||
| JP2018041560 | 2018-03-08 | ||
| JP2019014105 | 2019-01-30 | ||
| JP2019014105 | 2019-01-30 | ||
| PCT/JP2019/009015 WO2019172358A1 (ja) | 2018-03-08 | 2019-03-07 | Ｈｍｇｎ部分ペプチド及びこれを用いたがん療法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JPWO2019172358A1 JPWO2019172358A1 (ja) | 2021-03-11 |
| JPWO2019172358A5 true JPWO2019172358A5 (https=) | 2022-03-08 |
| JP7302793B2 JP7302793B2 (ja) | 2023-07-04 |
Family
ID=67846101
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020505099A Active JP7302793B2 (ja) | 2018-03-08 | 2019-03-07 | Ｈｍｇｎ部分ペプチド及びこれを用いたがん療法 |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US11572393B2 (https=) |
| EP (1) | EP3763731A4 (https=) |
| JP (1) | JP7302793B2 (https=) |
| TW (1) | TW201938580A (https=) |
| WO (1) | WO2019172358A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7302793B2 (ja) * | 2018-03-08 | 2023-07-04 | 国立大学法人 東京大学 | Ｈｍｇｎ部分ペプチド及びこれを用いたがん療法 |
| EP4215214A4 (en) * | 2020-09-16 | 2024-07-03 | Osaka University | THERAPEUTIC AGENT AGAINST CANCER, IMMUNOSTIMULANT AND SCREENING METHOD FOR ANTI-CANCER SUBSTANCE |
| CN114921443B (zh) * | 2022-05-05 | 2023-07-07 | 重庆医科大学 | 肺炎链球菌肽链内切酶o在制备抗肿瘤药物中的应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7544767B2 (en) | 2002-04-05 | 2009-06-09 | Burnham Institute For Medical Research | HMGN2 peptides and related molecules that selectively home to tumor blood vessels and tumor cells |
| US7714139B2 (en) * | 2003-03-27 | 2010-05-11 | Lankenau Institute For Medcial Research | IDO inhibitors and methods of use |
| US8227417B2 (en) | 2008-07-25 | 2012-07-24 | The United States Of America As Represented By The Secretary, Department Of Health And Human Services | HMGN polypeptides as immune enhancers and HMGN antagonists as immune suppressants |
| PT2374883T (pt) | 2008-12-26 | 2016-10-20 | Kyowa Hakko Kirin Co Ltd | Anticorpo anti-cd4 |
| US20110124564A1 (en) | 2009-08-25 | 2011-05-26 | Esperance Pharmaceuticals, Inc. | Nucleolin-binding peptides, nucleolin- binding lytic peptides, fusion constructs and methods of making and using same |
| WO2015125652A1 (ja) | 2014-02-21 | 2015-08-27 | Ｉｄａｃセラノスティクス株式会社 | 固形がんの治療剤 |
| WO2018047917A1 (ja) * | 2016-09-09 | 2018-03-15 | 国立大学法人 東京大学 | Ｈｍｇタンパク質と抗ｃｄ４抗体又は免疫チェックポイント制御剤との組み合わせによる相乗的抗腫瘍効果 |
| JP7302793B2 (ja) * | 2018-03-08 | 2023-07-04 | 国立大学法人 東京大学 | Ｈｍｇｎ部分ペプチド及びこれを用いたがん療法 |
-
2019
- 2019-03-07 JP JP2020505099A patent/JP7302793B2/ja active Active
- 2019-03-07 WO PCT/JP2019/009015 patent/WO2019172358A1/ja not_active Ceased
- 2019-03-07 TW TW108107562A patent/TW201938580A/zh unknown
- 2019-03-07 EP EP19764047.7A patent/EP3763731A4/en active Pending
- 2019-03-07 US US16/978,633 patent/US11572393B2/en active Active
-
2023
- 2023-01-03 US US18/092,737 patent/US11919932B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7170691B2 (ja) | 抗ｌａｇ３抗体およびその使用 | |
| AU2019301204B2 (en) | Antibody molecules that bind PD-L1 and CD137 | |
| KR102229512B1 (ko) | Pd-1/pd-l1 및 cd80(b7-1)/pd-l1 단백질/단백질 상호작용의 마크로시클릭 억제제 | |
| JP2017527272A5 (https=) | ||
| JP2019511212A5 (https=) | ||
| JP2020115874A (ja) | プログラム死−１（ｐｄ−１）に対する抗体 | |
| CN111133004A (zh) | 抗ctla-4抗体和其用途 | |
| JP2019506841A5 (https=) | ||
| HRP20220629T1 (hr) | Anti-cd73 antitijela i njihove upotrebe | |
| JP2016532693A5 (https=) | ||
| JP7274426B2 (ja) | 抗ｇｉｔｒアゴニスト抗体での癌の処置 | |
| EP3305812A1 (en) | Combination of dr5 agonist and anti-pd-1 antagonist and methods of use | |
| JP2020514363A5 (https=) | ||
| JP2019510739A5 (https=) | ||
| KR102832008B1 (ko) | Mica/b 유출을 차단하는 항-mica/b 항체 및 사용 방법 | |
| HRP20180753T1 (hr) | Antagonistička protutijela specifična za peptid koji je u vezi s genom za kalcitonin za liječenje cluster glavobolje | |
| JP2018501197A5 (https=) | ||
| FI3596116T3 (fi) | Immunomodulatorisia pd-l1-varianttiproteiineja ja niiden käyttöjä | |
| JP2020510662A5 (https=) | ||
| RS59688B1 (sr) | 5-bromo-2,6-di-(1h-pirazol-1-il)pirimidin-4-amin za upotrebu pri lečenju raka | |
| JP2018515088A5 (https=) | ||
| HRP20212023T1 (hr) | Modulokini temeljeni na il-15 i il-15ralpha sushi domeni | |
| WO2015189302A1 (en) | Antibodies directed against cd127 | |
| JPWO2019172358A5 (https=) | ||
| JP2016512213A5 (https=) |